Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
3
Number of overlapping holdings
10.0%
% of MEDX's 30 holdings also in PBE
10.7%
% of PBE's 28 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 5.9% | 4.8% | 4.8% |
|
REGENERON PHARMACEUTICALS | 2.7% | 4.5% | 2.7% |
|
BIOGEN IDEC INC | 2.4% | 4.7% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PBE
|
ELI LILLY & CO | 17.3% |
|
ABBVIE INC | 9.5% |
 |
NOVARTIS AG-ADR | 6.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.7% |
|
BRISTOL-MYERS SQUIBB CO | 5.6% |
|
JOHNSON & JOHNSON | 5.0% |
|
ALNYLAM PHARMACEUTICALS INC | 4.7% |
 |
ALKERMES PLC | 4.6% |
|
PFIZER INC | 3.9% |
|
MERCK & CO. INC. | 3.5% |
MEDX Underweight Relative to PBE
|
NATERA INC | -5.4% |
|
NEUROCRINE BIOSCIENCES INC | -5.1% |
|
GILEAD SCIENCES INC | -5.0% |
|
UNITED THERAPEUTICS CORP | -4.5% |
|
ILLUMINA INC | -4.4% |
|
TG THERAPEUTICS INC | -4.4% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.8% |
|
CATALYST PHARMACEUTICAL PART | -3.5% |
|
BLUEPRINT MEDICINES CORP. | -3.4% |
|
BIOCRYST PHARMACEUTICALS INC | -3.2% |